Dr. Herbert H. F. LOONG is a Clinical Associate Professor in the Department of Clinical Oncology, and the Deputy Medical Director of the Phase 1 Clinical Trials Centre, at The Chinese University of Hong Kong. He is also the founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.

Dr. Loong’s clinical and research interests focus on experimental therapeutics, sarcoma medical oncology, thoracic oncology and health economics. He has received the European Cancer Congress Fellowship grant, the American Society of Clinical Oncology (ASCO) Annual Meeting Merit Award and the Hong Kong College of Physicians Young Investigators’ Award. He also led the team who won the International Association for the Study of Lung Cancer (IASLC) Foundation Cancer Care Team Award in recognition for providing the best thoracic oncology care in the ’Asia & Rest of the World’ category in 2018.

Dr Loong has co-founded the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). He also serves on a range of international professional oncology bodies, such as the International Affairs Committee and the Asia Pacific Regional Council of ASCO; the Membership, Education and Communications committees of IASLC; and the Board Member of Connective Tissue Oncology Society (CTOS).

In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong during 2018-2023, he helps oversee the registration of medicinal products and clinical trials in the territory.